image

The best stocks to buy since 1993

Latest issue now available

Emis - Sales up 30% with double digit organic growth

February 2015

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • EMIS
  • Price:
  • 848p
A positive out turn for the year, with a trading update ahead of reporting on 18 March showing that 2014 revenues were +30% with “double digit organic growth” reported. The EMISWeb roll out is now largely complete (live in 4261 practices versus 3327) and the focus is turning to exploiting opportunities in pharmacy, community care & mental health and secondary care in particular. Net debt at the year end was £11.8m, down £1.7m.N+1 Singer forecasts eps of 45.1p for the current year with 49p next year. The PE is not high for a business that has terrific visibility of earnings and plays such a key part of the NHS’ five year commitment to a joined-up electronic health records system available to clinici ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe